Skip to main content
Journal cover image

Neuropsychiatric Comorbidities and Psychotropic Medication Use in Medicare Beneficiaries With Dementia by Sex and Race.

Publication ,  Journal Article
Johnson, KG; Ford, C; Clark, AG; Greiner, MA; Lusk, JB; Perry, C; O'Brien, R; O'Brien, EC
Published in: J Geriatr Psychiatry Neurol
January 2025

BACKGROUND: Neuropsychiatric symptoms affect the majority of dementia patients. Past studies report high rates of potentially inappropriate prescribing of psychotropic medications in this population. We investigate differences in neuropsychiatric diagnoses and psychotropic medication prescribing in a local US cohort by sex and race. METHODS: We utilize Medicare claims and prescription fill records in a cohort of 100% Medicare North and South Carolina beneficiaries ages 50 and above for the year 2017 with a dementia diagnosis. We identify dementia and quantify diagnosis of anxiety, depression and psychosis using validated coding algorithms. We search Medicare claims for antianxiety, antidepressant and antipsychotic medications to determine prescriptions filled. RESULTS: Anxiety and depression were diagnosed at higher rates in White patients; psychosis at higher rates in Black patients. (P < .001) Females were diagnosed with anxiety, depression and psychosis at higher rates than males (P < .001) and filled more antianxiety and antidepressant medications than males. (P < .001) Black and Other race patients filled more antipsychotic medications for anxiety, depression and psychosis than White patients. (P < .001) Antidepressants were prescribed at higher rates than antianxiety or antipsychotic medications across all patients and diagnoses. Of patients with no neuropsychiatric diagnosis, 11.4% were prescribed an antianxiety medication, 22.8% prescribed an antidepressant and 7.6% prescribed an antipsychotic. CONCLUSIONS: The high fill rate of antianxiety (benzodiazepine) medications in dementia patients, especially females is a concern. Patients are prescribed psychotropic medications at high rates. This practice may represent potentially inappropriate prescribing. Patient/caregiver education with innovative community outreach and care delivery models may help decrease medication use.

Duke Scholars

Published In

J Geriatr Psychiatry Neurol

DOI

EISSN

1552-5708

Publication Date

January 2025

Volume

38

Issue

1

Start / End Page

44 / 52

Location

United States

Related Subject Headings

  • White
  • United States
  • South Carolina
  • Sex Factors
  • Racial Groups
  • Psychotropic Drugs
  • Psychotic Disorders
  • Middle Aged
  • Medicare
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Johnson, K. G., Ford, C., Clark, A. G., Greiner, M. A., Lusk, J. B., Perry, C., … O’Brien, E. C. (2025). Neuropsychiatric Comorbidities and Psychotropic Medication Use in Medicare Beneficiaries With Dementia by Sex and Race. J Geriatr Psychiatry Neurol, 38(1), 44–52. https://doi.org/10.1177/08919887241254470
Johnson, Kim G., Cassie Ford, Amy G. Clark, Melissa A. Greiner, Jay B. Lusk, Cody Perry, Richard O’Brien, and Emily C. O’Brien. “Neuropsychiatric Comorbidities and Psychotropic Medication Use in Medicare Beneficiaries With Dementia by Sex and Race.J Geriatr Psychiatry Neurol 38, no. 1 (January 2025): 44–52. https://doi.org/10.1177/08919887241254470.
Johnson KG, Ford C, Clark AG, Greiner MA, Lusk JB, Perry C, et al. Neuropsychiatric Comorbidities and Psychotropic Medication Use in Medicare Beneficiaries With Dementia by Sex and Race. J Geriatr Psychiatry Neurol. 2025 Jan;38(1):44–52.
Johnson, Kim G., et al. “Neuropsychiatric Comorbidities and Psychotropic Medication Use in Medicare Beneficiaries With Dementia by Sex and Race.J Geriatr Psychiatry Neurol, vol. 38, no. 1, Jan. 2025, pp. 44–52. Pubmed, doi:10.1177/08919887241254470.
Johnson KG, Ford C, Clark AG, Greiner MA, Lusk JB, Perry C, O’Brien R, O’Brien EC. Neuropsychiatric Comorbidities and Psychotropic Medication Use in Medicare Beneficiaries With Dementia by Sex and Race. J Geriatr Psychiatry Neurol. 2025 Jan;38(1):44–52.
Journal cover image

Published In

J Geriatr Psychiatry Neurol

DOI

EISSN

1552-5708

Publication Date

January 2025

Volume

38

Issue

1

Start / End Page

44 / 52

Location

United States

Related Subject Headings

  • White
  • United States
  • South Carolina
  • Sex Factors
  • Racial Groups
  • Psychotropic Drugs
  • Psychotic Disorders
  • Middle Aged
  • Medicare
  • Male